{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T22:11:22Z","timestamp":1772316682891,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870525"],"award-info":[{"award-number":["81870525"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tsqn201909199"],"award-info":[{"award-number":["tsqn201909199"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"DOI":"10.1007\/s10103-023-03794-2","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T08:01:41Z","timestamp":1686211301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A systematic review and meta-analysis of efficacy and safety comparing greenlight laser vaporization with transurethral resection of the prostate for benign prostatic hyperplasia with prostate volume less than 80\u00a0ml"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0811-7900","authenticated-orcid":false,"given":"Shangjing","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongquan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huibao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengze","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9810-8145","authenticated-orcid":false,"given":"Zhongbao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"issue":"10","key":"3794_CR1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1046\/j.1442-2042.2002.00524.x","volume":"9","author":"A Hirayama","year":"2002","unstructured":"Hirayama A et al (2002) Comparison of parameters to determine the cause of urinary disturbance in men with prostate volume less than 20 milliliters. Int J Urol 9(10):554\u20139 (discussion 560)","journal-title":"Int J Urol"},{"issue":"6","key":"3794_CR2","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin DE et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50(6):1306\u201314 (discussion 1314-5)","journal-title":"Eur Urol"},{"issue":"2","key":"3794_CR3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10103-016-2122-5","volume":"32","author":"W Tao","year":"2017","unstructured":"Tao W et al (2017) The efficacy and safety of 2-\u03bcm continuous laser in the treatment of high-risk patients with benign prostatic hyperplasia. Lasers Med Sci 32(2):351\u2013356","journal-title":"Lasers Med Sci"},{"issue":"4","key":"3794_CR4","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/JU.0000000000002183","volume":"206","author":"LB Lerner","year":"2021","unstructured":"Lerner LB et al (2021) Management of lower urinary tract symptoms attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management. J Urol 206(4):806\u2013817","journal-title":"J Urol"},{"issue":"3 Pt 1","key":"3794_CR5","first-page":"784","volume":"160","author":"MC Michel","year":"1998","unstructured":"Michel MC et al (1998) Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does co-morbidity alter tolerability? J Urol 160(3 Pt 1):784\u2013791","journal-title":"J Urol"},{"issue":"11","key":"3794_CR6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2174\/1389450116666150518101617","volume":"16","author":"L Pirozzi","year":"2015","unstructured":"Pirozzi L et al (2015) Current pharmacological treatment for male LUTS due to BPH: Dutasteride or finasteride? Curr Drug Targets 16(11):1165\u20131171","journal-title":"Curr Drug Targets"},{"issue":"Suppl 3","key":"3794_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1464-410X.2008.07497.x","volume":"101","author":"CG Roehrborn","year":"2008","unstructured":"Roehrborn CG (2008) BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE. BJU Int 101(Suppl 3):17\u201321","journal-title":"BJU Int"},{"issue":"9\u201310","key":"3794_CR8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1159\/000514438","volume":"105","author":"F Cantiello","year":"2021","unstructured":"Cantiello F et al (2021) Mechanical and ablative minimally invasive techniques for male LUTS due to Benign prostatic obstruction: A systematic review according to BPH-6 evaluation. Urol Int 105(9\u201310):858\u2013868","journal-title":"Urol Int"},{"issue":"3","key":"3794_CR9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14728214.2017.1369953","volume":"22","author":"D Thomas","year":"2017","unstructured":"Thomas D et al (2017) Emerging drugs for the treatment of benign prostatic hyperplasia. Expert Opin Emerg Drugs 22(3):201\u2013212","journal-title":"Expert Opin Emerg Drugs"},{"issue":"5","key":"3794_CR10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.21037\/tau.2019.10.01","volume":"8","author":"SD Lokeshwar","year":"2019","unstructured":"Lokeshwar SD et al (2019) Epidemiology and treatment modalities for the management of benign prostatic hyperplasia. Transl Androl Urol 8(5):529\u2013539","journal-title":"Transl Androl Urol"},{"issue":"6","key":"3794_CR11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5489\/cuaj.11263","volume":"5","author":"PA Hueber","year":"2011","unstructured":"Hueber PA, Al-Asker A, Zorn KC (2011) Monopolar vs. bipolar TURP: assessing their clinical advantages. Can Urol Assoc J 5(6):390\u20131","journal-title":"Can Urol Assoc J"},{"issue":"6","key":"3794_CR12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.5489\/cuaj.10199","volume":"5","author":"CE M\u00e9ndez-Probst","year":"2011","unstructured":"M\u00e9ndez-Probst CE et al (2011) A multicentre single-blind randomized controlled trial comparing bipolar and monopolar transurethral resection of the prostate. Can Urol Assoc J 5(6):385\u2013389","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"3794_CR13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.juro.2008.03.058","volume":"180","author":"O Reich","year":"2008","unstructured":"Reich O et al (2008) Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 180(1):246\u2013249","journal-title":"J Urol"},{"issue":"5","key":"3794_CR14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","volume":"50","author":"J Rassweiler","year":"2006","unstructured":"Rassweiler J et al (2006) Complications of transurethral resection of the prostate (TURP)\u2013incidence, management, and prevention. Eur Urol 50(5):969\u201379 (discussion 980)","journal-title":"Eur Urol"},{"issue":"3","key":"3794_CR15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bju.15154","volume":"126","author":"S Madersbacher","year":"2020","unstructured":"Madersbacher S, Roehrborn CG, Oelke M (2020) The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia. BJU Int 126(3):317\u2013326","journal-title":"BJU Int"},{"issue":"3","key":"3794_CR16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00120-019-0891-8","volume":"58","author":"M Rieken","year":"2019","unstructured":"Rieken M, Herrmann TRW, F\u00fcllhase C (2019) Surgical treatment of benign prostatic hyperplasia-resection, vaporization or enucleation? Urologe A 58(3):263\u2013270","journal-title":"Urologe A"},{"issue":"1","key":"3794_CR17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2013.03.004","volume":"64","author":"M Oelke","year":"2013","unstructured":"Oelke M et al (2013) EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64(1):118\u2013140","journal-title":"Eur Urol"},{"issue":"1","key":"3794_CR18","first-page":"943","volume":"17","author":"QQ Meng","year":"2019","unstructured":"Meng QQ et al (2019) Tranexamic acid is beneficial for reducing perioperative blood loss in transurethral resection of the prostate. Exp Ther Med 17(1):943\u2013947","journal-title":"Exp Ther Med"},{"issue":"4","key":"3794_CR19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0090-4295(96)00247-6","volume":"48","author":"RS Kuntzman","year":"1996","unstructured":"Kuntzman RS et al (1996) Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology 48(4):575\u2013583","journal-title":"Urology"},{"issue":"5","key":"3794_CR20","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0090-4295(97)00232-X","volume":"49","author":"RS Kuntzman","year":"1997","unstructured":"Kuntzman RS et al (1997) High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology 49(5):703\u2013708","journal-title":"Urology"},{"issue":"4","key":"3794_CR21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00345-006-0094-y","volume":"24","author":"R Lee","year":"2006","unstructured":"Lee R, Gonzalez RR, Te AE (2006) The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia. World J Urol 24(4):405\u2013409","journal-title":"World J Urol"},{"issue":"4 Pt 1","key":"3794_CR22","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1097\/01.ju.0000173913.41401.67","volume":"174","author":"RS Malek","year":"2005","unstructured":"Malek RS, Kuntzman RS, Barrett DM (2005) Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol 174(4 Pt 1):1344\u20131348","journal-title":"J Urol"},{"issue":"1","key":"3794_CR23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/bju.14926","volume":"125","author":"FK Ghobrial","year":"2020","unstructured":"Ghobrial FK et al (2020) A randomized trial comparing bipolar transurethral vaporization of the prostate with GreenLight laser (xps-180watt) photoselective vaporization of the prostate for treatment of small to moderate benign prostatic obstruction: outcomes after 2 years. BJU Int 125(1):144\u2013152","journal-title":"BJU Int"},{"issue":"3","key":"3794_CR24","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10103-015-1721-x","volume":"30","author":"S Guo","year":"2015","unstructured":"Guo S et al (2015) The 80-W KTP GreenLight laser vaporization of the prostate versus transurethral resection of the prostate (TURP): adjusted analysis of 5-year results of a prospective non-randomized bi-center study. Lasers Med Sci 30(3):1147\u20131151","journal-title":"Lasers Med Sci"},{"issue":"1","key":"3794_CR25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/luts.12135","volume":"10","author":"N Kumar","year":"2018","unstructured":"Kumar N et al (2016) Prospective randomized comparison of monopolar TURP, Bipolar TURP and Photoselective vaporization of the prostate in patients with benign prostatic obstruction: 36 months outcome. Low Urin Tract Symptoms 10(1):17\u201320","journal-title":"Low Urin Tract Symptoms"},{"key":"3794_CR26","doi-asserted-by":"publisher","unstructured":"Mattevi D et al (2020) Comparison of GreenLight 180-W XPS laser vaporization versus transurethral resection of the prostate: Outcomes of a single regional center. Arch Ital Urol Androl 92(3). https:\/\/doi.org\/10.4081\/aiua.2020.3.169","DOI":"10.4081\/aiua.2020.3.169"},{"key":"3794_CR27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.urology.2018.01.037","volume":"116","author":"L Mordasini","year":"2018","unstructured":"Mordasini L et al (2018) 80-W greenlight laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic obstruction: 5-year outcomes of a single-center prospective randomized trial. Urology 116:144\u2013149","journal-title":"Urology"},{"issue":"8","key":"3794_CR28","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1464-410X.2011.10878.x","volume":"110","author":"JA Pereira-Correia","year":"2012","unstructured":"Pereira-Correia JA et al (2012) GreenLight HPS\u2122 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation. BJU Int 110(8):1184\u20131189","journal-title":"BJU Int"},{"key":"3794_CR29","doi-asserted-by":"crossref","unstructured":"Reimann M et al (2020) Outcome of photoselective vaporization of the prostate with the GreenLight-XPS 180 watt system compared to transurethral resection of the prostate. J Clin Med 8(7):1004.","DOI":"10.3390\/jcm8071004"},{"issue":"1","key":"3794_CR30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1756287214556643","volume":"7","author":"O Telli","year":"2015","unstructured":"Telli O et al (2015) A prospective, randomized comparative study of monopolar transurethral resection of the prostate versus photoselective vaporization of the prostate with GreenLight 120-W laser, in prostates less than 80 cc. Ther Adv Urol 7(1):3\u20138","journal-title":"Ther Adv Urol"},{"issue":"1","key":"3794_CR31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.eururo.2015.07.054","volume":"69","author":"JA Thomas","year":"2016","unstructured":"Thomas JA et al (2015) A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of Benign prostatic obstruction: two-yr outcomes of the GOLIATH study. Eur Urol 69(1):94\u2013102","journal-title":"Eur Urol"},{"issue":"7","key":"3794_CR32","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1089\/end.2007.0321","volume":"22","author":"V Tugcu","year":"2008","unstructured":"Tugcu V et al (2008) Comparison of photoselective vaporization of the prostate and transurethral resection of the prostate: a prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol 22(7):1519\u20131525","journal-title":"J Endourol"},{"issue":"3","key":"3794_CR33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.21614\/chirurgia.115.3.307","volume":"115","author":"C Ene","year":"2020","unstructured":"Ene C, Geavlete P, Geavlete B (2020) What\u2019s New in Bipolar TURP for Surgical Management of BPH? Chirurgia (Bucur) 115(3):307\u2013313","journal-title":"Chirurgia (Bucur)"},{"issue":"1","key":"3794_CR34","first-page":"36","volume":"3","author":"J Michalak","year":"2015","unstructured":"Michalak J, Tzou D, Funk J (2015) HoLEP: the gold standard for the surgical management of BPH in the 21(st) century. Am J Clin Exp Urol 3(1):36\u201342","journal-title":"Am J Clin Exp Urol"},{"issue":"1","key":"3794_CR35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/end.2005.19.25","volume":"19","author":"NM Fried","year":"2005","unstructured":"Fried NM, Murray KE (2005) High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. J Endourol 19(1):25\u201331","journal-title":"J Endourol"},{"issue":"4","key":"3794_CR36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00345-014-1410-6","volume":"33","author":"Y Zhu","year":"2015","unstructured":"Zhu Y et al (2015) Thulium laser versus standard transurethral resection of the prostate for benign prostatic obstruction: a systematic review and meta-analysis. World J Urol 33(4):509\u2013515","journal-title":"World J Urol"},{"issue":"1","key":"3794_CR37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00345-022-04201-1","volume":"41","author":"G Bozzini","year":"2023","unstructured":"Bozzini G et al (2023) Thulium: YAG vs continuous-wave thulium fiber laser enucleation of the prostate: do potential advantages of thulium fiber lasers translate into relevant clinical differences? World J Urol 41(1):143\u2013150","journal-title":"World J Urol"},{"issue":"1","key":"3794_CR38","first-page":"125","volume":"21","author":"B Xue","year":"2013","unstructured":"Xue B et al (2013) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a prospective randomized trial. J Xray Sci Technol 21(1):125\u2013132","journal-title":"J Xray Sci Technol"},{"issue":"6","key":"3794_CR39","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.eururo.2005.07.001","volume":"48","author":"A Bachmann","year":"2005","unstructured":"Bachmann A et al (2005) Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol 48(6):965\u201371 (discussion 972)","journal-title":"Eur Urol"},{"key":"3794_CR40","first-page":"263","volume":"13","author":"D Castellani","year":"2021","unstructured":"Castellani D et al (2021) GreenLight Laser\u2122 Photovaporization versus transurethral resection of the prostate: a systematic review and meta-analysis. Res Rep Urol 13:263\u2013271","journal-title":"Res Rep Urol"},{"issue":"6","key":"3794_CR41","first-page":"1121","volume":"27","author":"W Tao","year":"2019","unstructured":"Tao W et al (2019) Application of 180W XPS GreenLight laser vaporization of the prostate for treatment of benign prostatic hyperplasia. J Xray Sci Technol 27(6):1121\u20131129","journal-title":"J Xray Sci Technol"},{"issue":"3","key":"3794_CR42","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10103-016-1895-x","volume":"31","author":"Y Zhou","year":"2016","unstructured":"Zhou Y et al (2016) Greenlight high-performance system (HPS) 120-W laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a meta-analysis of the published results of randomized controlled trials. Lasers Med Sci 31(3):485\u2013495","journal-title":"Lasers Med Sci"},{"issue":"3","key":"3794_CR43","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jfma.2012.11.012","volume":"114","author":"TK Yang","year":"2015","unstructured":"Yang TK et al (2015) Body mass index and age are predictors for symptom improvement after high-power laser vaporization for benign prostatic hyperplasia. J Formos Med Assoc 114(3):268\u2013273","journal-title":"J Formos Med Assoc"},{"issue":"8","key":"3794_CR44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11934-015-0525-7","volume":"16","author":"BB Anderson","year":"2015","unstructured":"Anderson BB, Pariser JJ, Helfand BT (2015) Comparison of patients undergoing PVP Versus TURP for LUTS\/BPH. Curr Urol Rep 16(8):55","journal-title":"Curr Urol Rep"},{"issue":"1","key":"3794_CR45","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.juro.2012.08.093","volume":"189","author":"JJ Meeks","year":"2013","unstructured":"Meeks JJ et al (2013) Clinically significant prostate cancer is rarely missed by ablative procedures of the prostate in men with prostate specific antigen less than 4 ng\/ml. J Urol 189(1):111\u2013115","journal-title":"J Urol"},{"issue":"4","key":"3794_CR46","first-page":"755","volume":"27","author":"W Tao","year":"2019","unstructured":"Tao W et al (2019) Comparison of vaporization using 120-W GreenLight laser versus 2-micrometer continuous laser for treating benign prostatic hyperplasia: A 24-month follow-up study of a single center. J Xray Sci Technol 27(4):755\u2013764","journal-title":"J Xray Sci Technol"},{"issue":"Suppl 3","key":"3794_CR47","first-page":"S24","volume":"8 Suppl 3","author":"AE Te","year":"2006","unstructured":"Te AE (2006) The next generation in laser treatments and the role of the greenlight high-performance system laser. Rev Urol 8 Suppl 3(Suppl 3):S24-30","journal-title":"Rev Urol"},{"issue":"1","key":"3794_CR48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.euf.2018.04.020","volume":"4","author":"M Rieken","year":"2018","unstructured":"Rieken M, Kaplan SA (2018) Enucleation, vaporization, and resection: how to choose the best surgical treatment option for a patient with male lower urinary tract symptoms. Eur Urol Focus 4(1):8\u201310","journal-title":"Eur Urol Focus"},{"issue":"10","key":"3794_CR49","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1007\/s00345-021-03678-6","volume":"39","author":"ML Wroclawski","year":"2021","unstructured":"Wroclawski ML et al (2021) Shedding light on polypragmasy of pain after transurethral prostate surgery procedures: a systematic review and meta-analysis. World J Urol 39(10):3711\u20133720","journal-title":"World J Urol"},{"issue":"3","key":"3794_CR50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.eururo.2010.05.026","volume":"58","author":"A Al-Ansari","year":"2010","unstructured":"Al-Ansari A et al (2010) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 58(3):349\u2013355","journal-title":"Eur Urol"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-023-03794-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-023-03794-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-023-03794-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T06:03:55Z","timestamp":1703225035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-023-03794-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3794"],"URL":"https:\/\/doi.org\/10.1007\/s10103-023-03794-2","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,8]]},"assertion":[{"value":"10 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors had no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}],"article-number":"133"}}